Investigating Anosmia and Ageusia in COVID-19 Adult Patients in Saudi Arabia
NCT ID: NCT04388618
Last Updated: 2022-05-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
250 participants
OBSERVATIONAL
2020-06-15
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The COVID-19 infection severely affects the respiratory system in the critical cases and results in mortalities. The affected people experience a dry cough, fever, breathing problems, diarrhea, muscle pain, and sore throat. Besides that, some of the evidence from Italy, South Korea, China, and Spain suggest that the COVID-19 cases also lose their senses of smell and taste resulting in alterations in those patients.
The objective of this proposed study is to determine whether COVID-19 cases have Olfactory and gustatory dysfunctions as a hallmark indicator and can be used as diagnostic tools for the isolation of suspected people.
Investigators are presenting a prospective proportional case-control study that is conducted to investigate the COVID-19 cases with anosmia and /or Ageusia in a university hospital in Riyadh, Saudi Arabia. The sample size of this case series would be 250 cases of suspected COVID-19 patients. The cases included in the study are analyzed prospectively to determine if the cases had a history of anosmia and /or Ageusia, and then tested for the alteration of these senses through a panel of standardized odors/taste strips. That is looked at statistically allowing us to confirm the proposed effectiveness of these tests as a diagnostic tool.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Qualitative and Quantitative Evaluation of Anosmia Over Time in Clinically Symptomatic Patients Tested for COVID-19 Infection
NCT04354857
EFFECT OF COVID-19 DISEASE IN SMELL AND TASTE OF PATIENTS WITH MILD, MODERATE OR SEVERE SYMPTOMATOLOGY
NCT04657445
Frequency and Clinical Evolution of Olfactory and Taste Disorders in COVID-19 Patients
NCT04361565
Retrospective Study on Anosmias and Ageusias Linked to Infection by Covid-19
NCT04681157
Smell and Taste Disorders in COVID-19 Patients
NCT04427332
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Taste exam measures in NHANES The NHANES chemosensory tests used regional and whole mouth taste intensities of bitter and salt tastants as measures of taste function, which were similar to those implemented in the NIH Toolbox norming study. These NHANES taste measures were selected based on their ability to capture genetic and environmentally mediated variation in taste and for their potential relevance to diet and health.
Smell function in NHANES was assessed with an 8-item, odor identification test (Pocket Smell Tests™, Sensonics, Inc., Haddon Heights, NJ). Of many available psychophysical measures of olfactory function, odor identification tests are the most widely used in epidemiological and clinical settings, as they are quick, relatively inexpensive, and easy to administer. The odor identification test corresponds well with odor threshold tasks as well as other suprathreshold olfactory measures (e.g., discrimination, odor intensity), and hence is considered to be a rapid and accurate method for detecting olfactory dysfunction.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
covid19 positive patients
participants who present with signs and symptoms suspected for covid19 and swabbed/tested positive
NHANES smell and taste tests
participants will be asked to smell 8 cards of different odors and submit your choices in a given card, and so for 3 different taste tips (salty, bitter and neutral). participants will be asked to submit his choices in a given card as well. Then participants photograph those cards and send it via WhatsApp to a given number to be collected
covid19 negative patients
participants who present with signs and symptoms suspected for covid19 and swabbed/tested negative
NHANES smell and taste tests
participants will be asked to smell 8 cards of different odors and submit your choices in a given card, and so for 3 different taste tips (salty, bitter and neutral). participants will be asked to submit his choices in a given card as well. Then participants photograph those cards and send it via WhatsApp to a given number to be collected
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NHANES smell and taste tests
participants will be asked to smell 8 cards of different odors and submit your choices in a given card, and so for 3 different taste tips (salty, bitter and neutral). participants will be asked to submit his choices in a given card as well. Then participants photograph those cards and send it via WhatsApp to a given number to be collected
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
\-
Exclusion Criteria
2. Known patients with Kallmann's syndrome, CHARGE syndrome, Indifference to pain syndrome, ciliopathy disorders.
3. Known patient with congenital anomalies, absent smell sense, and absent taste sense.
4. Pregnant and lactating ladies
5. Patients with trigeminal nerve disease
6. Blind and deaf patients
7. Malingering.
8. Adults aged more than 65 years old.
9. Allergy to quinine products
\-
12 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Princess Nourah Bint Abdulrahman University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
osama y kentab
m.d, FAAP, FACEP , CLINICAL ASSOCIATE PROFESSOR OF EMERGENCY MEDICINE, SENIOR CONSULTANT PEDIATRIC EMERGENCY MEDICINE
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
OSAMA KENTAB, M.D
Role: PRINCIPAL_INVESTIGATOR
Princess Nourah Bint Abdulrahman University
AHMAD AALIBRAHIM, M.D
Role: STUDY_DIRECTOR
Princess Nourah Bint Abdulrahman University
MARZOOQA ALENIZI, M.D
Role: STUDY_CHAIR
Princess Nourah Bint Abdulrahman University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Princess Nourah Bint Abdulrahman Univeristy
Riyadh, Central, Saudi Arabia
prince Mohammed bin Abdulaziz Hospital
Riyadh, Central, Saudi Arabia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-01-R-059
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.